| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements
|
Takenaka, Masaru
|
|
|
30 |
2 |
p. 215-228
|
artikel
|
| 2 |
Age-related genomic alterations and chemotherapy sensitivity in osteosarcoma: insights from cancer genome profiling analyses
|
Outani, Hidetatsu
|
|
|
30 |
2 |
p. 397-406
|
artikel
|
| 3 |
Analysis of lung cancer incidence, mortality trends, and smoking rates in Japan:1975–2022 with insights on the impact of COVID-19
|
Yamamoto, Hiroki
|
|
|
30 |
2 |
p. 199-209
|
artikel
|
| 4 |
A prospective study comparing highly qualified Molecular Tumor Boards with AI-powered software as a medical device
|
Bando, Hideaki
|
|
|
30 |
2 |
p. 172-179
|
artikel
|
| 5 |
Celebrating 30 years of IJCO: shaping the future of clinical oncology
|
Mandai, Masaki
|
|
|
30 |
2 |
p. 169
|
artikel
|
| 6 |
Comprehensive epidemiology of melanoma at all sites: insights from Japan’s National Cancer Registry, 2016–2017
|
Ogata, Dai
|
|
|
30 |
2 |
p. 194-198
|
artikel
|
| 7 |
Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomy
|
Nishikawa, Kazuhiro
|
|
|
30 |
2 |
p. 320-329
|
artikel
|
| 8 |
Discovery and validation of Hsa-microRNA-3665 promoter methylation as a potential biomarker for the prognosis of esophageal squaous cell carcinoma
|
Zhou, Jinsong
|
|
|
30 |
2 |
p. 309-319
|
artikel
|
| 9 |
Effects of aging on complications following robot-assisted radical prostatectomy
|
Koterazawa, Shigeki
|
|
|
30 |
2 |
p. 340-350
|
artikel
|
| 10 |
Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1
|
Goto, Hideki
|
|
|
30 |
2 |
p. 389-396
|
artikel
|
| 11 |
Efficacy of androgen receptor signaling inhibitors in combination with androgen deprivation therapy for castration-sensitive metastatic prostate cancer: a retrospective analysis in a Japanese cohort
|
Taga, Minekatsu
|
|
|
30 |
2 |
p. 351-357
|
artikel
|
| 12 |
Evaluating the impact of atezolizumab on febrile neutropenia occurrence in patients with NSCLC undergoing chemotherapy in Japan: a real-world post-marketing database study
|
Nakane, Sayuri
|
|
|
30 |
2 |
p. 298-308
|
artikel
|
| 13 |
Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumors
|
Li, Jin
|
|
|
30 |
2 |
p. 241-251
|
artikel
|
| 14 |
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan
|
Matsumura, Noriomi
|
|
|
30 |
2 |
p. 170-171
|
artikel
|
| 15 |
Postoperative adjuvant therapy with molecularly targeted agents for non-small cell lung cancer
|
Miyoshi, Tomohiro
|
|
|
30 |
2 |
p. 210-214
|
artikel
|
| 16 |
Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures
|
Jiang, Wenjie
|
|
|
30 |
2 |
p. 277-297
|
artikel
|
| 17 |
Prognostic significance of lymph node metastasis of soft tissue sarcoma of the extremities. National cancer institute experience
|
Shalaby, Mohamed
|
|
|
30 |
2 |
p. 407-416
|
artikel
|
| 18 |
Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer
|
Honda, Kazunori
|
|
|
30 |
2 |
p. 380-388
|
artikel
|
| 19 |
Relationship between patient-reported health-related quality of life as measured with the SF-36 or SF-12 and their mortality risk in patients with diverse cancer type: a meta-analysis
|
Tanaka, Takashi
|
|
|
30 |
2 |
p. 252-266
|
artikel
|
| 20 |
Robotic dual-docking surgery for para-aortic lymphadenectomy in endometrial cancer: a prospective feasibility study
|
Yanazume, Shintaro
|
|
|
30 |
2 |
p. 358-370
|
artikel
|
| 21 |
The clinical significance of signal regulatory protein alpha expression in the immune environment of gastric cancer
|
Tanaka, Yasushi
|
|
|
30 |
2 |
p. 330-339
|
artikel
|
| 22 |
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience
|
Yunokawa, Mayu
|
|
|
30 |
2 |
p. 371-379
|
artikel
|
| 23 |
Transforming cancer screening: the potential of multi-cancer early detection (MCED) technologies
|
Imai, Mitsuho
|
|
|
30 |
2 |
p. 180-193
|
artikel
|
| 24 |
Treatment-related skin reactions in enfortumab vedotin as a surrogate marker of survival and treatment response
|
Nagayama, Jun
|
|
|
30 |
2 |
p. 267-276
|
artikel
|
| 25 |
Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors
|
Jo, Ami
|
|
|
30 |
2 |
p. 229-240
|
artikel
|
Tijdschrift beschrijving